Oculis Holding (OCS) Stock Price, Quote, News & History

Comments

Oculis Holding AG (OCS) Stock Price, Quote, News & History

OCSNASDAQ

Trade with Public

$27.42

0.461.71%

At close: Mar 9, 5:00 PM EST

$27.42

N/A

After Hours: 4:00 PM EST

Earnings: Q4 2025 Earnings were released on Tue Mar 3rd, after the market close

OverviewNews Earnings Analyst Ratings Short Interest Stock Report

Key Statistics

Open

$26.40

Close

$27.42

Volume / Avg.

288.03K / 254.95K

Day Range

$26.25 - $27.50

52 Wk Range

14.00 - 30.68

Market Cap

$1.59B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

0.75%

Days to Cover

1.25

Recent Oculis Holding AG News

Microchip Technology, Alumis, Terrestrial Energy, Bright Minds Biosciences And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

This AeroVironment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Avi Kapoor

This Linde Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-66.30M

Investing Cash Flow (TTM)

-60.93M

Financing Cash Flow (TTM)

186.92M

Free Cash Flow (TTM)

-67.69M

Capital Expenditure (TTM)

-1.39M

Net Change in Cash (TTM)

59.68M

Analyst Trends and Forecast

2

Oct 25

4

Nov 25

3

Dec 25

3

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.32B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

6.29

Earnings Yield % (TTM)

-8.89%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$4.36

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$373.00K

Total Cash

$81.33M

Debt to Equity

0.01

Issuance of Debt (TTM)

-$373.00K

Repayment of Debt (TTM)

-$373.00K

Key Statistics

Open

$26.40

Close

$27.42

Volume / Avg.

288.03K / 254.95K

Day Range

$26.25 - $27.50

52 Wk Range

14.00 - 30.68

Market Cap

$1.59B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

0.75%

Days to Cover

1.25

About

Sector

Health Care

Industry

Pharmaceuticals

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED);...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Oculis Holding (OCS) stock?

A

You can purchase shares of Oculis Holding (NASDAQ:OCS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Oculis Holding (OCS) competitors?

A

Other companies in Oculis Holding’s space includes: GH Research PLC (NASDAQ:GHRS), AtaiBeckley Inc (NASDAQ:ATAI), Xeris Biopharma Holdings Inc (NASDAQ:XERS), Phibro Animal Health Corp (NASDAQ:PAHC) and Rapport Therapeutics Inc (NASDAQ:RAPP).

Q

What is the forecast, or price target, for Oculis Holding (OCS) stock?

A

Oculis Holding has a consensus price target of $41.89.

Q

What is the current price for Oculis Holding (OCS)?

A

The stock price for Oculis Holding (NASDAQ: OCS) is $27.42 last updated March 9, 2026 at 4:00 PM EDT.

Q

Does Oculis Holding (OCS) pay a dividend?

A

There are no upcoming dividends for Oculis Holding.

Q

When is Oculis Holding (NASDAQ:OCS) reporting earnings?

A

Oculis Holding does not have any upcoming earnings scheduled.

Q

Is Oculis Holding (OCS) going to split?

A

There is no upcoming split for Oculis Holding.

Q

What sector and industry does Oculis Holding (OCS) operate in?

A

Oculis Holding is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch

Xeris Biopharma Holdings Inc

NASDAQ:XERS

$5.58

-0.36%

Phibro Animal Health Corp

NASDAQ:PAHC

$49.75

1.99%

Rapport Therapeutics Inc

NASDAQ:RAPP

$30.71

0.56%

ANI Pharmaceuticals Inc

Key Statistics

Open

$26.40

Close

$27.42

Volume / Avg.

288.03K / 254.95K

Day Range

$26.25 - $27.50

52 Wk Range

14.00 - 30.68

Market Cap

$1.59B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

0.75%

Days to Cover

1.25

Recent Oculis Holding AG News

Microchip Technology, Alumis, Terrestrial Energy, Bright Minds Biosciences And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

This AeroVironment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Avi Kapoor

This Linde Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-66.30M

Investing Cash Flow (TTM)

-60.93M

Financing Cash Flow (TTM)

186.92M

Free Cash Flow (TTM)

-67.69M

Capital Expenditure (TTM)

-1.39M

Net Change in Cash (TTM)

59.68M

Analyst Trends and Forecast

2

Oct 25

4

Nov 25

3

Dec 25

3

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.32B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

6.29

Earnings Yield % (TTM)

-8.89%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$4.36

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$373.00K

Total Cash

$81.33M

Debt to Equity

0.01

Issuance of Debt (TTM)

-$373.00K

Repayment of Debt (TTM)

-$373.00K

Key Statistics

Open

$26.40

Close

$27.42

Volume / Avg.

288.03K / 254.95K

Day Range

$26.25 - $27.50

52 Wk Range

14.00 - 30.68

Market Cap

$1.59B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

0.75%

Days to Cover

1.25

About

Sector

Health Care

Industry

Pharmaceuticals

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED);...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry